PUBLICATIONS

Clinical Research Focus. 49th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of February 2026. Read more

After JPM 2026: Where Healthcare Strategy Is Actually Heading By Vlad Bogin, MD, FACP CEO, Cromos Pharma The J.P. Morgan Healthcare Conference has always been a defining moment for the healthcare industry, not because of a single announcement, but because of the collective direction that emerges once the week is over. JPM 2026 followed that pattern, but with a noticeable shift in tone. This Read more

Clinical Research in 2026: What Changed — and Why It Matters  Key Takeaways   Clinical research is becoming more selective, not slower.  Capital, regulation, and policy volatility are forcing sharper prioritization and earlier decisions.  Execution quality now carries financial consequences.  Late-stage trials leave little room for operational error, weak endpoints, or slow enrollment.  Risk is moving upstream.  AI, alternative preclinical models, and modular global development are shifting decision-making earlier.  Read more

Neurology CRO: A Practical Guide to Running Successful CNS Clinical Trials Clinical trials in neurology remain among the most complex andhigh-riskin drug development. High placebo response, slow disease progression, subjective endpoints, and patient retention challenges consistently contribute to failure rates that exceed many other therapeutic areas.  This is why sponsors increasingly turn to a neurology CRO — not just a general clinical research organization with CNS experience, but a partner built to Read more